Caprock Group, Inc. Abb Vie Inc. Transaction History

Caprock Group, Inc.

$1.72 Billion
Q1 2024

A detailed history of Caprock Group, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Caprock Group, Inc. holds 22,068 shares of ABBV stock, worth $3.66 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

22,068

Previous 19,570 12.76%

Holding current value

$3.66 Million

Previous $3.03 Million 32.52%

% of portfolio

0.23%

Previous 0.2%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	BUY	$159.82 - $182.1 $399,230 - $454,885	2,498 Added 12.76%	22,068 $4.02 Million
Q4 2023 Jan 18, 2024	BUY	$137.6 - $154.97 $432,476 - $487,070	3,143 Added 19.13%	19,570 $3.03 Million
Q3 2023 Oct 18, 2023	BUY	$133.59 - $154.65 $38,340 - $44,384	287 Added 1.78%	16,427 $2.45 Million
Q2 2023 Aug 10, 2023	SELL	$132.51 - $164.9 $295,762 - $368,056	-2,232 Reduced 12.15%	16,140 $2.17 Million
Q1 2023 Apr 26, 2023	BUY	$144.61 - $166.54 $327,541 - $377,213	2,265 Added 14.06%	18,372 $2.93 Million

Q4 2022 Jan 23, 2023	SELL	$138.31 - $165.87 $301,377 - $361,430	-2,179 Reduced 11.92%	16,107 $0
Q3 2022 Nov 07, 2022	SELL	$134.21 - $153.93 $97,704 - $112,061	-728 Reduced 3.83%	18,286 $2.45 Million
Q2 2022 Jul 26, 2022	BUY	$137.62 - $174.96 $92,480 - $117,573	672 Added 3.66%	19,014 $2.91 Million
Q1 2022 Apr 12, 2022	SELL	$131.98 - $163.75 $161,939 - $200,921	-1,227 Reduced 6.27%	18,342 $2.97 Million
Q4 2021 Jan 18, 2022	SELL	$107.43 - $135.93 $356,130 - $450,607	-3,315 Reduced 14.49%	19,569 $2.65 Million
Q3 2021 Oct 07, 2021	BUY	$106.4 - $120.78 $314,199 - $356,663	2,953 Added 14.82%	22,884 $2.47 Million
Q2 2021 Aug 13, 2021	SELL	$105.21 - $117.21 $254,608 - $283,648	-2,420 Reduced 10.83%	19,931 $2.25 Million
Q1 2021 Apr 29, 2021	SELL	$102.3 - $112.62 $673,338 - $741,264	-6,582 Reduced 22.75%	22,351 $2.42 Million
Q4 2020 Jan 29, 2021	SELL	$80.49 - $108.67 $173,938 - $234,835	-2,161 Reduced 6.95%	28,933 $3.1 Million
Q3 2020 Oct 29, 2020	SELL	$85.91 - $100.83 $191,665 - $224,951	-2,231 Reduced 6.69%	31,094 $2.72 Million
Q2 2020 Aug 05, 2020	BUY	$73.37 - $98.18 $669,941 - $896,481	9,131 Added 37.74%	33,325 $3.27 Million
Q1 2020 Apr 28, 2020	BUY	$64.5 - $97.79 $229,684 - $348,230	3,561 Added 17.26%	24,194 $1.84 Million
Q4 2019 Feb 04, 2020	BUY	$72.13 - $90.25 $63,185 - $79,059	876 Added 4.43%	20,633 $1.83 Million
Q3 2019 Oct 31, 2019	BUY	$62.98 - $75.72 $386,193 - $464,315	6,132 Added 45.01%	19,757 $1.5 Million
Q2 2019 Jul 23, 2019	SELL	$65.7 - $83.98 $28,185 - $36,027	-429 Reduced 3.05%	13,625 $991,000
Q1 2019 Apr 12, 2019	BUY	$77.14 - $90.79 $106,376 - $125,199	1,379 Added 10.88%	14,054 $1.13 Million
Q4 2018 Jan 29, 2019	BUY	$77.85 - $96.01 $70,376 - $86,793	904 Added 7.68%	12,675 $1.17 Million
Q3 2018 Oct 17, 2018	SELL	$88.91 - $98.84 $37,342 - $41,512	-420 Reduced 3.45%	11,771 $1.11 Million
Q2 2018 Jul 23, 2018	SELL	$89.78 - $106.23 $384,976 - $455,514	-4,288 Reduced 26.02%	12,191 $1.13 Million
Q1 2018 Apr 23, 2018	SELL	$92.01 - $123.21 $137,186 - $183,706	-1,491 Reduced 8.3%	16,479 $1.56 Million
Q4 2017 Jan 17, 2018	SELL	$89.56 - $98.21 $179,299 - $196,616	-2,002 Reduced 10.02%	17,970 $1.82 Million
Q3 2017 Oct 23, 2017	BUY	$69.85 - $89.22 $1.4 Million - $1.78 Million	19,972	19,972 $1.78 Million

Others Institutions Holding ABBV

# of Institutions

3,652

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $293B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caprock Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Caprock Group, Inc. with notifications on news.

Account

Caprock Group, Inc. Abb Vie Inc. Transaction History